Mohamed Abdo Rizk Selected Research

diminazene aceturate

12/2021	Evaluation of the inhibitory effect of Zingiber officinale rhizome on Babesia and Theileria parasites.
2/2020	Myrrh Oil in Vitro Inhibitory Growth on Bovine and Equine Piroplasm Parasites and Babesia microti of Mice.
10/2019	Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review.
1/2018	The effects of nitidine chloride and camptothecin on the growth of Babesia and Theileria parasites.
10/2017	Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice.
8/2017	Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites.
8/2014	Evaluation of a fluorescence-based method for antibabesial drug screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed Abdo Rizk Research Topics

Disease

17	Babesiosis (Piroplasmosis) 01/2022 - 02/2016
5	Malaria 12/2021 - 08/2014
4	Infections 01/2021 - 12/2017
2	Tick-Borne Diseases (Tick-Borne Disease) 01/2021 - 11/2020
1	Burns 05/2022
1	Corneal Ulcer 05/2022
1	Body Weight (Weight, Body) 01/2022
1	Hematoma 01/2022
1	Abscess 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Abdominal Hernia (Abdominal Hernias) 01/2022
1	Pneumonic Pasteurellosis (Shipping Fever) 11/2021
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Digital Dermatitis 11/2021
1	Toxoplasmosis 01/2021
1	Cysts 01/2021
1	Bronchopneumonia 12/2017
1	Parasitemia 10/2017
1	Urinary Tract Infections (Urinary Tract Infection) 02/2016
1	Gonorrhea 02/2016
1	Coinfection 02/2016
1	Bacterial Infections (Bacterial Infection) 02/2016
1	Theileriasis 02/2016

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 08/2017
7	diminazene aceturateIBA 12/2021 - 08/2014
3	VaccinesIBA 01/2021 - 12/2017
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 12/2017
2	Interferon-gamma (Interferon, gamma)IBA 11/2021 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 12/2017
2	CytokinesIBA 11/2021 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 02/2016
2	pyronaridineIBA 04/2021 - 10/2017
2	tert-butylserineIBA 01/2021 - 11/2020
2	AntigensIBA 01/2021 - 11/2019
2	imidocarb dipropionateIBA 10/2019 - 01/2018
1	AlkaliesIBA 05/2022
1	pycnogenolsIBA 05/2022
1	naphthoquineIBA 01/2022
1	Clofazimine (Lamprene)FDA Link 01/2022
1	Polypropylenes (Polypropylene)IBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2021
1	Interleukin-1 (Interleukin 1)IBA 11/2021
1	InterleukinsIBA 11/2021
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 11/2021
1	Phenytoin (Dilantin)FDA LinkGeneric 11/2021
1	Biological ProductsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	18S Ribosomal RNAIBA 01/2021
1	Attenuated VaccinesIBA 01/2021
1	myrrh oilIBA 02/2020
1	Dihydrotachysterol (AT 10)IBA 02/2020
1	ImmunosorbentsIBA 11/2019
1	EnzymesIBA 11/2019
1	Antimalarials (Antimalarial Agents)IBA 10/2019
1	thymoquinoneIBA 01/2019
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2018
1	Atovaquone (Mepron)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	tulathromycinIBA 12/2017
1	flunixin meglumine (Banamine)IBA 12/2017
1	Therapeutic UsesIBA 12/2017
1	allicinIBA 10/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2017
1	Enoxacin (AT 2266)FDA Link 02/2016
1	FluoroquinolonesIBA 02/2016
1	Nalidixic Acid FDA Link 02/2016

Therapy/Procedure

2	Therapeutics 01/2022 - 04/2021
1	Oral Administration 01/2022
1	Herniorrhaphy 01/2022
1	Sutures (Suture) 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 10/2017